Therefore, we propose a summarizing algorithm (depicted in Fig. 8) as a starting point for clinical trials assessing the predictive significance of TS expression in patients with stage B2 + C colon cancer subjected to 5FU-based adjuvant chemotherapy. This evidence concerns the gene TYMS and colonic neoplasm.